ABSTRACT
INTRODUCTION
Oral cancer is eleventh most common cancer in the world and account for two-third of deaths in developing countries [1] . In India 47,653 deaths due to oral cancer are registered in 2008 according to Global Cancer Statistics, 2011 [2] . The most strenuous problem in oral cancer is presence of metastasis right at the time of diagnosis. Currently lack of an easy-to-use and inexpensive sampling method and lack of an accurate and portable platform to understand the pathogenesis of the disease are the major limitations which have seriously hampered the development of appropriate clinical diagnostics. Early detection and ideal biomarkers are needed for controlling the disease progression, which may dramatically reduce the severity of its impact on the patients' life. Matrix metalloproteinases (MMPs) are the enzymes which plays important role in metastasis and invasion by proteolytic degradation of extracellular matrix (ECM), disruption of cell-cell and cell matrix adhesion, migration and angiogenesis [3] [4] [5] . Earlier reports have suggested the loss of E-cadherin, a cell adhesion molecule in oral precancerous conditions (OPC) [6] . Further MMPs are well-known for modulating the cell-cell and cell-ECM interactions affecting both cell phenotype (epithelial mesenchymal transition) and increasing cell migration 3 . Hence, understanding MMPs in oral precancerous conditions would help in monitoring early events in tumorigenesis. MMP-9, a gelatinase causes degradation of type IV collagen. MMP-9 levels are up-regulated in various malignancies including colorectal, gastric, thyroid, ovarian, bladder, lung, larynx, pancreatic, prostate cancer and oral cancer [5, [7] [8] [9] . Most of the studies correlating MMPs with cancer outcome have analyzed tissue/plasma specimen.
Earlier reports have indicated elevated tissues and plasma levels of MMP-9 in oral cancer patients [7] [8] [9] . Earlier studies have indicated weak up-regulation of MMP-9 mRNA in tissues of oral lichen planus and dysplastic lesions [10] .
Although MMPs are known as key mediators of cancer invasion, their involvement in oral premalignant conditions is not documented. Saliva offers an attractive non-invasive tool for assessing biomarkers in oral cancer due to its direct contact with sites of the lesions. Recently there is eye catching advancement in salivary based diagnostics [11] [12] [13] . Various gelatinolytic activities were observed in saliva and studies have suggested a 42kDa truncated form of enzyme which was due to autoactivation of gelatinolytic MMPs [14] . Gelatin zymography offers the advantage of estimating both pro and active forms of gelatinases (MMPs) [7, 9] . Hence in the present study gelatin zymography was performed which is cost effective alternative to ELISA method [7] .
As per our knowledge there are no earlier reports on simultaneous evaluation in patients with OPC and oral cancer of salivary MMP-9 and truncated 42 kDa MMP. Studying MMPs in premalignant lesions might help in monitoring the early changes occurring during oral cancer progression. Hence, the present study was undertaken to evaluate salivary levels of gelatinolytic MMP-9 and truncated 42 kDa MMP in patients with OPC and oral cancer patients to understand the utility of saliva a non-invasive tool in monitoring changes occurring during neoplastic transformation of oral cancer. to avoid any possible diurnal variation in the study. For saliva collection standard protocols were followed [16] . Briefly the subjects rinsed their mouth thoroughly with water and then threw off that water. Unstimulated whole saliva was collected in 50 ml falcon tube kept on ice, and was processed immediately. The saliva was centrifuged at 2600g for 15 minutes at 4°C. The supernatant was collected in different aliquots and protease inhibitors were added as follows: 1µl
MATERIALS AND METHODS
Aprotinin (1mg/ml), 3µl Sodium orthovananadate (40mM), and 1µl Phenyl methyl sulfonyl fluoride (PMSF) (1mg/ml) was added in 100µl of saliva supernatant [16] . After the addition of protease inhibitors the saliva supernatants were immediately stored at -80°C until analyzed.
Total Proteins: Total protein levels from saliva were determined using the Lowry's method [17] . Briefly, after mixing 10µl of saliva samples with 490µl of distilled water and 2.25 ml of Reagent C, the reaction mixture was incubated for 10 minutes at room temperature. Thereafter, 0.25 ml FolinCiocalteau reagent was added and after incubation for 30 minutes, the tubes were read spectrophotometrically at 750 nm. The standard curve was prepared using bovine serum albumin (Sigma, USA) as standard in concentration range of 10-60 μg.
Gelatin zymography: Gelatin Zymography was performed using SDS-PAGE (containing 0.5mg/ml gelatin) electrophoresis as described by Lorenzo, et al. [18] . For standardization, zymography was performed using a broad range of protein concentrations and finally 10µg of salivary protein was standardized. Subsequently in the experiments, 10µg of salivary protein was mixed with sample buffer dye without reducing agent and electrophoresed on 7.5% polyacrylamide gel at 4°C. Gels were washed and incubated overnight in 50mM Tris HCl pH 7.5; containing 10mL CaCl2, 1uM ZnCl2, 0.02% (W/V) NaN3 and 1% (V/V) Triton X-100. Next day, the gels were stained with 0.1% (W/V) Coomassie Brilliant Blue R-250 and destained in 7% (V/V) acetic acid. The bands appeared as clear bands against a dark background. These zymograms were quantitated using gel documentation system (Alpha Innotech, USA). The As depicted in Fig. 1 and Fig. 2 the expression of salivary pro MMP-9 and active MMP-9 were found to be significantly higher (P<0.001) in oral cancer patients as compared to the controls, also the levels were found to be significantly higher (P=0.01 and P=0.001 respectively) in oral cancer patients as compared to the patients with OPC. Moreover, an increasing trend was observed from controls to patients with OPC to oral cancer patients. The truncated form of MMP i.e. of 42 kDa was observed to have gelatinolytic activity. As illustrated in Fig. 1 , the expression of truncated 42kDa MMP was found to be significantly higher in oral cancer patients (p<0.001) as compared to the controls. In addition, the levels were found to be higher in patients with OPC as compared to controls and an increasing trend was observed from controls to patients with OPC to oral cancer patients.
Activation ratio i.e. active MMP-9/Total MMP-9 was found to be elevated in patients with OPC as compared to the controls (P=0.07). Also the activation ratio was found to be significantly elevated in oral cancer patients as compared to the controls (P<0.001). An increasing trend was observed from controls to patients with OPC to oral cancer patients.
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When the levels were further compared between non-habituates (NHT) and subjects with habit of tobacco (WHT), the mean values of pro MMP-9 and active MMP-9 were found to be higher in WHT controls as compared to NHT controls, while truncated 42 kDa MMP levels were comparable. The levels were comparable between NHT oral cancer patients and WHT oral cancer patients.
Increased Expression of Salivary Pro MMP-9, Active MMP-9 and Truncated 42kDa MMP in Advanced Disease as Compared to Early Disease
As documented in Fig. 3 , the levels of pro MMP-9, active MMP-9 and truncated 42 kDa were found to be significantly higher in advanced stage of disease as compared to controls (P=0.007, P=0.010, P<0.001, respectively). The levels of truncated 42 kDa MMP were found to be significantly elevated in early disease as compared to controls (P=0.05). Also, the levels of pro MMP-9, active MMP-9 and truncated 42 kDa MMP were found to be higher in advanced disease as compared to early disease (P=0.746, P=0.694 and P=0.086 respectively). The activation ratio of MMP-9 was found to be significantly higher in advanced disease as compared to the controls (P=0.019). The activation ratio was found to be higher in advanced disease as compared to early disease.
Higher Expression of Pro MMP-9, Active MMP-9 and Truncated MMP 42 kDa in

Patients with Lymph-Node (LN) Metastasis as Compared to the Patients without LN
Metastasis
As documented in Fig. 4 , the levels of pro MMP-9, active MMP-9 and truncated 42 kDa MMP were found to be significantly higher in patients with LN metastasis (P=0.007, P=0.026 and P=0.004 respectively) and without LN metastasis (P=0.022, P=0.042 and P=0.085 respectively) as compared to controls. Also, the levels were found to be higher in patients with LN metastasis as compared to patients without LN metastasis. The activation ratio of MMP-9 was found to be higher in patients with metastasis as compared to patients without metastasis.
Multivariate analysis depicted significant positive correlation of truncated 42 kDa MMP with infiltration (F=4.165, P=0.049).
Significant Positive Correlation between All Forms of MMPs
Pearson's correlation analysis was performed to evaluate the correlation between different forms of MMPs. The results revealed that salivary pro MMP-9, active MMP-9 and truncated 42 kDa MMP were significantly (P<0.0001) positively correlated as shown in Table 2 . 
DISCUSSION
Saliva can serve as an excellent fluid to study salivary MMPs, as it is in direct contact with oral cancer lesions. MMPs have been known to be involved in disruption of cell-cell and cell-ECM interactions. Earlier reports have indicated truncation of E-cadherin, a cell adhesion molecule in patients with OPC [6] . As loss of E-cadherin is an early event in oral cancer progression, understanding MMPs in precancerous conditions might help in predicting metastatic behavior of the disease. Gelatin zymography is a cost effective technique which is able to detect both pro and active forms of gelatinases. There is a dearth of study on salivary MMP-9 in patients with OPC and oral cancer, hence the present study was undertaken to understand utility of salivary MMP-9 in monitoring changes occurring during neoplastic transformation of oral cancer. An increasing trend of salivary pro and active MMP-9 was observed from controls to patients with OPC to oral cancer patients. Earlier studies have indicated elevated levels of tissues MMP-9 in benign, premalignant and malignant laryngeal lesions [19] . Earlier salivary MMP-9 levels have been examined in patients with periodontitis [20] and have indicated bands corresponding to higher molecular mass complexes as well as low molecular sized components representing truncated MMP species. Earlier reports have suggested that 42 kDa MMP is the truncated form of MMP which is expressed due to autoactivation of various other gelationolytic MMPs [14] . Moreover, salivary protease activity was very high in saliva, in the present investigation. Hence, a truncated species of 42 kDa MMP was observed which might be due to proteolytic activities of other MMPs. High molecular weight gelatinases and truncated lower molecular weight species of gelatinases were also observed by Ingman, et al. [21] in periodontitis patients, which represented invivo proteolytically activated truncated enzymes. In the present study, an increasing trend of truncated 42 kDa MMP was observed from controls to patients with OPC to oral cancer patients. The levels of pro MMP-9, active MMP-9 and truncated MMP 42 kDa were found to be significantly higher in oral cancer patients as compared to the controls.
Earlier reports have indicated elevated levels of pro and active MMP-9 in tissues and plasma of oral cancer patients as compared to the controls [7] [8] [9] . Moreover, in the present study a band of 125 kDa was observed which possessed gelatinolytic activity. It has been earlier reported that MMP-9 is associated with 25 kDa protein (microglobulin), giving a band at 125 kDa [22] .
Studies have indicated elevated levels of MMP-9 after areca quid chewing in healthy volunteers and an elevation in oral cancer patients who are betel quid users [23, 24] .
However, in the present study no significant difference was observed between tobacco habituates as compared to non-habituates for pro and active MMP-9. The results indicated that pro MMP-9, active MMP-9 and truncated MMP 42 kDa levels were higher in patients with LN metastasis as compared to patients without LN metastasis. Earlier reports have indicated elevated levels of tissue and plasma MMP-9 in patients with metastasis as compared to the patients without metastasis [7] [8] [9] 25 ]. All forms of MMPs i.e. Pro MMP-9, active MMP-9 and truncated 42 kDa were found to be higher in patients with advanced disease as compared to early disease.
Previous investigations have documented positive correlation of plasma MMP-9 with stage of disease [5] .
In conclusion, the results indicated increasing trend of pro MMP-9, active MMP-9, MMP-9 activation ratio and truncated 42 kDa MMP from controls to patients with OPC to oral cancer.
This clearly represents significant involvement of MMPs (gelatinases) in sequential changes occurring during oral cancer progression. The results exhibited potential utility of saliva, a non invasive tool in monitoring changes occurring during oral cancer progression and also to predict metastatic behavior. The present study revealed salivary MMPs as an ideal tumor marker with necessary characteristics including its non-invasiveness, cost-effectiveness and reproducibility, which can be ideally used in clinics; outpatient doors (OPDs)/screening programmes with minimum basic facilities and primary infrastructure.
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